Transvaginal mesh manufacturer Johnson & Johnson faced the first of nearly 1,800 trials in New Jersey state court alleging that faulty surgical mesh implants caused pain, nerve damage, scarring and organ perforation. Lawsuits against Ethicon, the division of Johnson & Johnson that makes transvaginal surgical mesh products, claim the manufacturer failed to adequately warn of vaginal mesh risks.
Linda Gross of South Dakota reports having 18 operations to repair damage caused by Johnson & Johnson’s Gynecare Prolift transvaginal mesh device since it was implanted in 2006. Gross is unable to continue working as a nurse due to the pain and discomfort caused by her transvaginal mesh implant. Johnson & Johnson claims that Gross was warned of risks associated with the transvaginal mesh prior to surgery.
The Gynecare Prolift transvaginal mesh device was originally approved by the FDA without significant clinical testing after manufacturers claimed the implant was similar to mesh products already on the market. Johnson & Johnson halted the sale of several of its transvaginal mesh products, including the Gynecare Prolift devices, in August 2012 citing lack of “commercial viability.”